Raleigh Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
16,651
+1,446
| +10% | +$268K | 1.3% | 10 |
|
|
2025
Q1 | $3.19M | Buy |
15,205
+545
| +4% | +$114K | 1.44% | 9 |
|
|
2024
Q4 | $2.61M | Buy |
14,660
+2,608
| +22% | +$463K | 1% | 16 |
|
|
2024
Q3 | $2.38M | Sell |
12,052
-162
| -1% | -$32K | 0.92% | 18 |
|
|
2024
Q2 | $2.09M | Sell |
12,214
-769
| -6% | -$132K | 0.89% | 22 |
|
|
2024
Q1 | $2.36M | Sell |
12,983
-4,239
| -25% | -$772K | 1.02% | 16 |
|
|
2023
Q4 | $2.67M | Buy |
17,222
+647
| +4% | +$100K | 1.24% | 15 |
|
|
2023
Q3 | $2.47M | Buy |
16,575
+143
| +0.9% | +$21.3K | 1.26% | 13 |
|
|
2023
Q2 | $2.21M | Sell |
16,432
-2,658
| -14% | -$358K | 1.1% | 19 |
|
|
2023
Q1 | $3.04M | Buy |
19,090
+587
| +3% | +$93.6K | 1.51% | 8 |
|
|
2022
Q4 | $2.99M | Buy |
18,503
+821
| +5% | +$133K | 1.56% | 10 |
|
|
2022
Q3 | $2.37M | Buy |
17,682
+1,379
| +8% | +$185K | 1.39% | 11 |
|
|
2022
Q2 | $2.5M | Sell |
16,303
-1,726
| -10% | -$264K | 1.42% | 11 |
|
|
2022
Q1 | $2.92M | Buy |
18,029
+1,872
| +12% | +$304K | 1.58% | 9 |
|
|
2021
Q4 | $2.19M | Buy |
+16,157
| New | +$2.19M | 2.24% | 9 |
|